ENVERIC BIOSCIENCES, INC. (ENVB) Operating cash flow 2016–2025
ENVERIC BIOSCIENCES, INC. (ENVB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.1MFY2025 · since FY2016: -$2.7M → -$8.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.1M | -5.4% |
| FY2024 | -$7.7M | +45.2% |
| FY2023 | -$14.1M | +17.8% |
| FY2022 | -$17.1M | -49.7% |
| FY2021 | -$11.5M | -194.6% |
| FY2020 | -$3.9M | -500.3% |
| FY2019 | -$647,860 | +74.7% |
| FY2018 | -$2.6M | +6.4% |
| FY2017 | -$2.7M | -1.4% |
| FY2016 | -$2.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENVB financial trends
ENVB RevenueENVB Net incomeENVB Net marginENVB Gross profitENVB Gross marginENVB Operating incomeENVB Operating marginENVB Free cash flowENVB Capital expendituresENVB Return on equityENVB Stock buybacksENVB Dividends paidENVB Total assetsENVB Total liabilitiesENVB Shareholders’ equityENVB overview →